AGLAIA ONCOLOGY FUNDS
Aglaia Oncology Funds is a financial service company that provides investment funds in the research of anti-cancer drugs.
AGLAIA ONCOLOGY FUNDS
Social Links:
Industry:
Biotechnology Financial Services Funding Platform Oncology
Founded:
2004-01-01
Address:
Bilthoven, Utrecht, The Netherlands
Country:
The Netherlands
Website Url:
http://www.aglaia-oncology.com
Total Employee:
1+
Status:
Active
Contact:
+31-30-229-6090
Email Addresses:
[email protected]
Technology used in webpage:
ReCAPTCHA ReCAPTCHA V2 Dutch Server Location
Similar Organizations
Avstera Therapeutics
Avstera Therapeutics is an oncology-focused biotech company that fulfil unmet needs of cancer patients.
BioAdvance
BioAdvance is a Pennsylvania-based venture capital firm that provides funding to life sciences startups.
CDR-Life AG
CDR-Life AG is a biotech company that develops innovative therapeutic antibody fragments with a focus on immuno-oncology.
FMO
FMO is a financial investment firm that specializes in financing businesses and projects.
Maven Capital Partners
Maven Capital Partners is a private equity firm that provides a range of funding options to SMEs and investment opportunities.
Navrogen
Navrogen is a biopharmaceutical company focused on the targeted treatment of cancer.
Pinpoint Therapeutics
Pinpoint Therapeutics is a preclinical stage company developing novel cancer treatment options aimed to specifically inhibit autophagy.
PIQUR Therapeutics
PIQUR Therapeutics is a Swiss pharmaceutical company focusing on the discovery and development of anti-cancer drugs.
UCEA
UCEA is a single family office that offers investment opportunities across the sports, healthcare, financial inclusion, and energy sectors.
Current Employees Featured
Founder
Official Site Inspections
http://www.aglaia-oncology.com Semrush global rank: 16.08 M Semrush visits lastest month: 1
- Host name: vps11.websteen.nl
- IP address: 178.22.56.75
- Location: Netherlands
- Latitude: 52.3824
- Longitude: 4.8995
- Timezone: Europe/Amsterdam
More informations about "Aglaia Oncology Funds"
Aglaia Oncology Funds | Investing in the Fight Against Cancer
Jul 11, 2024 Aglaia is an oncology specialist investor which selects and matures early-stage breakthrough inventions that have the potential to transform cancer prevention, diagnosis and …See details»
Aglaia Oncology Funds - Crunchbase Company Profile …
Aglaia Oncology Funds is a financial service company that provides investment funds in the research of anti-cancer drugs. New. Resources. Advanced …See details»
Aglaia Oncology Funds and Sinzer - Grant Thornton …
Aglaia offers investors an opportunity to combine an attractive financial return with a meaningful impact on healthcare and society. For more information about …See details»
Aglaia Oncology Funds - CB Insights
Dec 31, 2005 Aglaia offers investors an opportunity to combine an attractive financial return with a meaningful impact on healthcare and society. About Sinzer - Grant Thornton Sinzer is part of …See details»
Aglaia Oncology Funds - LinkedIn
Aglaia Oncology Funds | 486 volgers op LinkedIn. Investing in the fight against cancer | Aglaia is an investment fund fully focused on the fight against cancer and the development of improved …See details»
Aglaia Oncology Fund II: Performance - PitchBook
Aglaia Oncology Fund II is a 2014 vintage early stage venture capital fund managed by Aglaia Oncology Funds. The fund is located in Bilthoven, Netherlands. The fund targets …See details»
Investors - Cristal Therapeutics
The Dutch venture capital firm Aglaia – through its Oncology Funds I and II – invests in ground-breaking technologies that have the potential to translate into solutions for the prevention and …See details»
Aglaia Oncology Growth Opportunities Fund - PitchBook
Aglaia Oncology Growth Opportunities Fund is a private equity growth expansion fund managed by Aglaia Oncology Funds. The fund is located in Bilthoven, Netherlands. Contact InformationSee details»
InteRNA Technologies Establishes Clinical Advisory Board and …
Oct 19, 2021 Utrecht, The Netherlands, October 19, 2021 – InteRNA Technologies a clinical-stage biotech company developing microRNA (miRNA)-based therapeutics with a focus on …See details»
Aglaia Oncology Seed Fund B.V. · Professor Bronkhorstlaan 10G 92 ...
Aglaia Oncology Seed Fund B.V. (LEI# 724500NIE1D6JG3K2S92) is a legal entity registered with Kamer van Koophandel. The address is Professor Bronkhorstlaan 10G 92, Bilthoven, …See details»
Eric van der Putten - Partner at Aglaia Oncology Funds - The Org
Eric van der Putten has an extensive background in the field of oncology drug development and clinical trials. With experience in various companies and roles such as Non-Executive Director …See details»
List of the 200 largest Oncology Venture Capital Investors [2025]
Feb 28, 2025 Oncology startups are working on drugs against cancer, being active in one of the most important research fields in the pharmaceutical industry. In the following, we highlight …See details»
Inthera Bioscience raises CHF 10.5 million in ... - Aglaia Oncology …
The Dutch venture capital firm Aglaia – through its Oncology Funds I and II – invests in ground-breaking technologies that have the potential to translate into solutions for the prevention and …See details»
Navigating the right deals in oncology - Nature
Aglaia Oncology Funds, which invests in oncology start-ups. Oncopreneur provides consultancy and management services to oncology start-ups. Ernst Geutjes is alsoSee details»
Alan Barge Profile: Contact Information & Network | PitchBook
He serves as an Advisor at Aglaia Oncology Funds. He serves as Chairman at Modra Pharmaceuticals. He serves as Vice President at ASLAN Pharmaceuticals and Chief Medical …See details»
InteRNA Technologies joins TI Pharma by signing new project to …
InteRNA Technologies was incorporated in 2006 by Aglaia Oncology Fund and has established close relationships with the research groups of its founders Edwin Cuppen, PhD, and Eugene …See details»
Modra Pharmaceuticals Appoints Two New ... - aglaia-oncology.com
Apr 27, 2021 appointment of Hemanshu Shah, Ph.D., MBA and Klaus Schollmeier, Ph.D. to its supervisory board. The new members bring more than 50 years of combined experience in the …See details»
Eric Putten Profile: Contact Information & Network | PitchBook
Putten serves as a Partner at Aglaia Oncology Funds. His 30 years of clinical research experience derives from the Comprehensive Cancer Center where he started his career in 1983 as the …See details»
Organizations | Oncology Nursing Society
What sets ONS apart from other organizations is that it's focused on nursing practice. I think that's something that you won't find out there with some of the other organizations and obviously not …See details»
Cristal Therapeutics raises €12.8 million in new financing round to ...
The financing comes from a consortium headed by Dutch oncology investor Aglaia BioMedical Ventures and Belgian DROIA Oncology Ventures and was complemented by BOM, LIOF and …See details»